«Radiotherapy:
Novel lung cancer treatment meets with success.»
Not exact matches
Cancer Institute research highlights include innovative studies to develop individualized approaches for treatment and prevention of lung cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develo
Cancer Institute research highlights include innovative studies to develop individualized approaches for
treatment and prevention of
lung cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develo
cancer; collaboration between medical and materials science researchers to develop
treatments for various types of leukemia using nanotechnology to target only
cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develo
cancer cells; and development of
novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor development.
Clinical Trials Research and Billing First in Human / Early Phase PET in Oncology Case - Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine Therapy for Hyperthyroidism: The State of the Art Spondylodiscitis: Role of Imaging for Diagnosis and Monitoring
Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment Models and Value - Based Health Care: Nuts and Bolts Maximal Tolerated Activity of Radioactive Iodine for Metastatic Thyroid
Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging of
Lung Inflammation Standardization of Advanced PET / SPECT Data Acquisition and Analysis Thyroid
Cancer Management:
Novel Therapeutics and Management Options Targeting Radionuclide Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?
Novel drug therapies and novel indications of drug therapy, e.g. tyrosine kinase inhibitors in lung disease other than lung cancer, biological treatments for asthma, COPD, cystic fibrosis and interstitial lung dis
Novel drug therapies and
novel indications of drug therapy, e.g. tyrosine kinase inhibitors in lung disease other than lung cancer, biological treatments for asthma, COPD, cystic fibrosis and interstitial lung dis
novel indications of drug therapy, e.g. tyrosine kinase inhibitors in
lung disease other than
lung cancer, biological
treatments for asthma, COPD, cystic fibrosis and interstitial
lung disease.
The company's initial goal is to identify and deploy therapeutic neo-antigens from individual patients» tumors to develop
novel treatments for
lung cancer.
Professional clinical and research interests include biomarkers of
cancer and chemotherapy toxicity,
novel chemotherapy drugs and
treatments, and more recently inhalant chemotherapy and exhaled breath condensate evaluate in the monitoring and
treatment of primary and metastatic
lung cancer.